PMC:7502678 / 18168-18781 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T93","span":{"begin":89,"end":97},"obj":"Disease"},{"id":"T94","span":{"begin":185,"end":193},"obj":"Disease"},{"id":"T95","span":{"begin":404,"end":412},"obj":"Disease"},{"id":"T96","span":{"begin":472,"end":480},"obj":"Disease"},{"id":"T97","span":{"begin":604,"end":612},"obj":"Disease"}],"attributes":[{"id":"A93","pred":"mondo_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A94","pred":"mondo_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A95","pred":"mondo_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A96","pred":"mondo_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/MONDO_0005027"},{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T73","span":{"begin":120,"end":121},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T74","span":{"begin":340,"end":341},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T75","span":{"begin":459,"end":460},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T21","span":{"begin":259,"end":276},"obj":"Chemical"},{"id":"T22","span":{"begin":372,"end":375},"obj":"Chemical"}],"attributes":[{"id":"A21","pred":"chebi_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/CHEBI_35705"},{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_73494"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"363","span":{"begin":390,"end":398},"obj":"Species"},{"id":"364","span":{"begin":89,"end":97},"obj":"Disease"},{"id":"365","span":{"begin":185,"end":193},"obj":"Disease"},{"id":"366","span":{"begin":324,"end":329},"obj":"Disease"},{"id":"367","span":{"begin":404,"end":412},"obj":"Disease"},{"id":"368","span":{"begin":472,"end":480},"obj":"Disease"},{"id":"369","span":{"begin":604,"end":612},"obj":"Disease"}],"attributes":[{"id":"A363","pred":"tao:has_database_id","subj":"363","obj":"Tax:9606"},{"id":"A364","pred":"tao:has_database_id","subj":"364","obj":"MESH:C000657245"},{"id":"A365","pred":"tao:has_database_id","subj":"365","obj":"MESH:C000657245"},{"id":"A366","pred":"tao:has_database_id","subj":"366","obj":"MESH:D005334"},{"id":"A367","pred":"tao:has_database_id","subj":"367","obj":"MESH:C000657245"},{"id":"A368","pred":"tao:has_database_id","subj":"368","obj":"MESH:D004827"},{"id":"A369","pred":"tao:has_database_id","subj":"369","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T75","span":{"begin":324,"end":329},"obj":"Phenotype"},{"id":"T76","span":{"begin":472,"end":480},"obj":"Phenotype"}],"attributes":[{"id":"A75","pred":"hp_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A76","pred":"hp_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/HP_0001250"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}

{"project":"0_colil","denotations":[{"id":"32942901-32327490-1073","span":{"begin":206,"end":208},"obj":"32327490"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}

{"project":"TEST0","denotations":[{"id":"32942901-206-212-1073","span":{"begin":206,"end":208},"obj":"[\"32327490\"]"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}

{"project":"2_test","denotations":[{"id":"32942901-32327490-28639245","span":{"begin":206,"end":208},"obj":"32327490"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T140","span":{"begin":0,"end":98},"obj":"Sentence"},{"id":"T141","span":{"begin":99,"end":330},"obj":"Sentence"},{"id":"T142","span":{"begin":331,"end":613},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}

{"project":"MyTest","denotations":[{"id":"32942901-32327490-28639245","span":{"begin":206,"end":209},"obj":"32327490"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Respondents in the current survey did not notice an increase in susceptibility of PWE to COVID-19. This is supported by a consensus statement which finds no increased risk of acquiring COVID-19 in most PWE.13 Exceptions include PWE who are being treated with immunosuppressant medications or those particularly sensitive to fever. However, a recent study that reported on EEG findings in 8 patients with COVID-19 related neurologic problems found 5 (63%) had a history of epilepsy.10 These authors raised the concern that PWE may be at increased risk developing neurologic manifestations if they acquire COVID-19."}